Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in South Korea / NCT02792075
Recruiting Observational

Prognosis of Coronary Stenosis Based on Intracoronary Imaging; A Multicenter, Prospective Observational Study

NCT02792075 · tracked via the Priya Life Science South Korea tracker
Sponsor
Seung-Jung Park
Phase
Observational
Started
2016-07
Last updated
2026-01-02

Condition(s) studied

Coronary Artery Disease

Investigational drug(s) / intervention(s)

5-year Follow-up

Study summary

The purpose of this study is to evaluate the prognosis of coronary stenosis based on intracoronary Imaging.

Eligibility

Sex
ALL
Min age
19 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients with intracoronary imaging * Written consent Exclusion Criteria: * Severe calcification and/or severe tortuosity * Lesion with previous bypass graft surgery (CABG) * Left ventricular ejection fraction less than 30 % * Coronary spasm * Life expectancy less than 2 years * Pregnancy or breast-feeding

Primary outcome measure(s)

  • Target Vessel Failure — 2 years
    defined as composite event of cardiac death, non-fatal myocardiac infarction, target vessel revascularization

Trial sites (15)

FacilityCityRegionStatus
Asan Medical Center Seoul Songpa-gu Recruiting
Inje University Busan Paik Hospital Busan South Korea Recruiting
Soon Chun Hyang University Hospital Cheonan Cheonan South Korea Recruiting
Keimyung University Dongsan Medical Center Daegu South Korea Recruiting
Chungnam National University Hospital Daejeon South Korea Recruiting
Inje University Ilsan Paik Hospital Ilsan South Korea Recruiting
Gachon University Gil Hospital Incheon South Korea Terminated
Jeju national university hospital Jeju City South Korea Recruiting
Pusan National University Hospital Pusan South Korea Recruiting
Chung-Ang university hospital Seoul South Korea Recruiting
Kangbuk Samsung Hospital Seoul South Korea Withdrawn
Korea University Guro Hospital Seoul South Korea Recruiting
Ajou University Hospital Suwon South Korea Active Not Recruiting
Ulsan University Hospital Ulsan South Korea Withdrawn
Wonju Severance Christian Hospital Wŏnju South Korea Recruiting

More Seung-Jung Park trials in South Korea

Study of the Natural History of FFR Guided Percutaneous Coronary Intervention Recruiting
Evaluation of Effectiveness and Safety of Rotational Atherectomy in Routine Clinical Practice Recruiting
Observational Study for Left Main Disease Treatment Recruiting
Asan Multivessel Registry Recruiting
IRIS-Onyx Cohort in the IRIS-DES Registry Active, not recruiting

Other trials for the same condition

Clinical Impact of Orsiro™ Stent in Patient With Chronic Kidney Disease Active, not recruiting
The COMPLETE Treatment of Bifurcation With Two-stent Techniques: Randomized Comparison of Crush Versus Culotte Technique Recruiting
CREATE Trial, Prospective, Observational Study Active, not recruiting
Study of the Natural History of FFR Guided Percutaneous Coronary Intervention Recruiting
Safety and Efficacy of Paclitaxel Coated PTCA Balloon Catheter With a Shellac Plus Vitamin E Excipient (GENOSS® DCB) in Patients With Coronary In-stent Restenosis (ISR): A Prospective, Multi-center, Observational Study Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT02792075 on ClinicalTrials.gov ↗ ← All trials in South Korea